Marvell (MRVL) PT Raised to $29 at Cowen Following Cavium Deal; 'Organic Growth Plus Highly Synergistic Deal'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. SMCI
6. GOOGL
7. RTX
8. COF
9. TSLA
10. CRWV

Go back to Marvell (MRVL) PT Raised to $29 at Cowen Following Cavium Deal; 'Organic Growth Plus Highly Synergistic Deal'

Marvell (MRVL) PT Raised to $28 at BofA/Merrill Lynch; Reiterates Buy

November 29, 2017 7:27 AM EST

BofA/Merrill Lynch raised its price target on Marvell (NASDAQ: MRVL) to $28.00 (from $26.00) while maintaining a Buy rating following the company's 3Q earnings release. Sales were reported 1% ahead, with pf-EPS 3% ahead vs. the original outlook.

The most important takeaway from the call was... More

Marvell (MRVL) PT Raised to $29 at KeyBanc Following 3Q; Reiterates Overweight

November 29, 2017 7:19 AM EST

KeyBanc raised its price target on Marvell (NASDAQ: MRVL) to $29.00 (from $25.00) while maintaining a Overweight rating following the company's 3Q release. Revenue of $616M exceeded estimates of $610M, driven by better strength in connectivity. Higher revenue and lower operating expenses drove EPS to $0.34, above... More